This inventor holds 3 USPTO granted patents. Top assignee: Jcr Pharmaceuticals Co., Ltd.. Active years: 1998-2000.
Company Filing History:
Years Active: 1998-2000
Title: Keihide Koh: Innovator in Biopharmaceuticals
Introduction
Keihide Koh is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of biopharmaceuticals, particularly in the purification of glycoproteins and the development of suppressory agents against hypercoagulation. With a total of 3 patents to his name, Koh's work has the potential to impact medical treatments and therapies.
Latest Patents
Koh's latest patents include a process for purifying Tamm-Horsfall glycoprotein (THG) and uromodulin. This invention provides a method that enhances the efficiency of purification through a simplified procedure, allowing for better discrimination between the two proteins. Another significant patent involves the development of suppressory agents against hypercoagulation. This invention features a protein C inhibitor with a molecular weight of 54 to 57 kDa, which is capable of suppressing the function of the blood coagulation system.
Career Highlights
Koh is currently associated with JCR Pharmaceuticals Co., Ltd., where he continues to innovate in the biopharmaceutical sector. His work is characterized by a focus on improving therapeutic processes and enhancing patient outcomes through advanced scientific methods.
Collaborations
Koh has collaborated with notable colleagues such as Yoshikazu Komurasaki and Satoshi Nishimuro. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Keihide Koh's contributions to the field of biopharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work not only enhances purification processes but also addresses critical issues in blood coagulation, showcasing the importance of innovation in healthcare.